Abstract
Purpose: Dissolution dynamic nuclear polarization (DNP) enables the acquisition of 13C magnetic resonance data with a high sensitivity. Recently, metabolically inactive hyperpolarized 13C-labeled compounds have shown to be potentially useful for perfusion imaging. The purpose of this study was to validate hyperpolarized perfusion imaging methods by comparing with conventional gadolinium (Gd)-based perfusion MRI techniques and pathology. Methods: Dynamic 13C data using metabolically inactive hyperpolarized bis-1,1-(hydroxymethyl)-[1-13C]cyclopropane-d8 (HMCP) were obtained from an orthotopic human glioblastoma (GBM) model for the characterization of tumor perfusion and compared with standard Gd-based dynamic susceptibility contrast (DSC) MRI data and immunohistochemical analysis from resected brains. Results: Distinct HMCP perfusion characteristics were observed within the GBM tumors compared with contralateral normal brain tissue. The perfusion parameters obtained from the hyperpolarized HMCP data in tumor were strongly correlated with normalized peak height measured from the DSC images. The results from immunohistochemical analysis supported these findings by showing a high level of vascular staining for tumor that exhibited high levels of hyperpolarized HMCP signal. Conclusion: The results from this study have demonstrated that hyperpolarized HMCP data can be used as an indicator of tumor perfusion in an orthotopic xenograft model for GBM. Magn Reson Med 77:841–847, 2017.
Original language | English |
---|---|
Pages (from-to) | 841-847 |
Number of pages | 7 |
Journal | Magnetic resonance in medicine |
Volume | 77 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2017 |
Keywords
- brain tumor
- dynamic nuclear polarization
- gadolinium dynamic susceptibility contrast imaging
- hyperpolarized C perfusion MRI